Search results
How Should You Play Merck (MRK) Stock Ahead of Q1 Earnings?
Zacks via Yahoo Finance· 6 days agoInvestor focus is likely to be on the sales of Merck's (MRK) blockbuster oncology medicine, Keytruda...
Immutep Announces Positive Preliminary Topline Results from TACTI-003 Cohort B
Morningstar· 4 days agoMedia Release Data from efti in combination with KEYTRUDA® in first line head and neck squamous cell carcinoma patients who do not express PD-L1 (TACTI-003, Cohort B) shows ...
Merck Stock Gains On Its Blockbuster Cancer Drug Keytruda, Raises Annual Outlook
Benzinga via Yahoo Finance· 3 days agoOn Thursday, U.S. drug maker Merck & Co Inc (NYSE:MRK) reported first-quarter sales of $15.8...
Man receives world’s first melanoma vaccine — trial underway
New York Post· 2 days agoSome of the participants will get a placebo shot though none will know what they are receiving....
British patients test world’s first personalised mRNA jab for melanoma
Press Association News via AOL· 3 days agoPhase 2 data, published in December, found that people with serious high-risk melanomas who received...
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 4 days agoModerna stock is yo-yoing after the company unveiled early-stage test results for its...
Merck stock gains on Q1 2024 beat (NYSE:MRK)
Seeking Alpha· 3 days agoMerck (MRK) stock gains as the company posts better than expected Q1 2024 financials with strong sales growth from its cancer medicine Keytruda. Read...
Merck’s first-quarter results beat expectations amid healthy vaccine-sales growth
Market Watch· 3 days agoMerck & Co. Inc. on Thursday reported first-quarter results that beat analysts’ expectations amid...
Merck Raises 2024 Profit Forecast on Strong Sales of Cancer Drug Keytruda
US News & World Report· 3 days agoKeytruda, the world's top selling drug in 2023, has been Merck's key revenue driver over the past few years and is expected to top $30 billion in sales by 2026 before losing ...
Cancer jab offers hope of a cure as NHS trials vaccines that 'destroy melanoma'
The US Sun· 2 days agoTHE world's first personalised mRNA cancer jab for melanoma is being tested in British patients. The...